Американское общество гирудотерапии

Dilemmas in the diagnosis and management of antiphospholipid syndrome.

Case report published in Journal of thrombosis and haemostasis : JTH (2024)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportКлинические исследованияРазработка лекарственных препаратовManning et al. · Journal of thrombosis and haemostasis : JTH, 2024

Abstract

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous, arterial, or microvascular) and/or pregnancy morbidity in association with persistently positive antiphospholipid antibodies. Although thrombosis and pregnancy morbidity are the main clinical criteria for a diagnosis of APS in the revised Sapporo (Sydney) criteria, recently published American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for APS have significantly refined the diagnostic algorithm to include a scoring system clustered into 6 clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular thrombosis, obstetric, cardiac valve, and hematologic). Diagnosis of APS is complicated by the fact that significant heterogeneity exists in patients' clinical presentation, underlying vascular risk factors, and methods of detecting antiphospholipid antibodies. Despite the autoimmune nature of APS, anticoagulation remains the main strategy for secondary prevention of thrombosis. Furthermore, optimal antithrombotic treatment in APS patients with arterial thrombosis remains controversial due to a paucity of data from randomized controlled studies. In this paper, we present 2 cases and highlight the diagnostic and therapeutic challenges they pose and how we approach them in the light of current evidence.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal ArticleReview
Indexed MeSH termsFemaleHumansMalePregnancyAntibodies, AntiphospholipidAnticoagulantsAntiphospholipid SyndromePredictive Value of TestsRisk FactorsThrombosisTreatment Outcome

Резюме

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous, arterial, or microvascular) and/or pregnancy morbidity in association with persistently positive antiphospholipid antibodies. Although thrombosis and pregnancy morbidity are the main clinical criteria for a...

Почему это важно для гирудотерапии

This review with case presentations examines diagnostic and therapeutic challenges in antiphospholipid syndrome (APS), including clinical heterogeneity, antibody detection difficulties, and controversies in antithrombotic management. The authors discuss how anticoagulation remains the main strategy for secondary prevention of thrombosis in APS, while optimal treatment for arterial thrombosis remains controversial due to limited randomized controlled trial data. The abstract contains no mention of leeches, hirudotherapy, hirudin, or leech-derived anticoagulants. There is no defensible connection to ASH's domain, as the article focuses entirely on conventional pharmaceutical management and classification criteria.

Цитирование

Dilemmas in the diagnosis and management of antiphospholipid syndrome.

Manning et al. · Journal of thrombosis and haemostasis : JTH, 2024

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 28, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.